This page is kept for reference and is not offered to search engines.
In other countries
The same active substances on other registers, the same brand first.
- SifrolEuropean Union · Boehringer Ingelheim International GmbHSame brand
- SifrolCroatiaSame brand
- Sifrol 0,088 mg, tablettenNetherlands · Tablet · Boehringer Ingelheim International GmbHSame brand
- Sifrol 0,18 mg, tablettenNetherlands · Tablet · Boehringer Ingelheim International GmbHSame brand
- Sifrol 0,26 mg, tabletten met verlengde afgifteNetherlands · Tablet met verlengde afgifte · Boehringer Ingelheim International GmbHSame brand
- Sifrol 0.088 MG (Equ.0.125MG) TabSaudi Arabia · Boehringer IngelheimSame brand
- Sifrol 0.18 MG (Equ.0.25MG) TabSaudi Arabia · Boehringer IngelheimSame brand
- Sifrol 0.7MG (Equ. 1.00MG) TabSaudi Arabia · Boehringer IngelheimSame brand
- Sifrol Extended Release Tablet 0.375 mgSingapore · 0.375mg · tablet, extended release · Boehringer Ingelheim Singapore Pte. LTD.Same brand
- Sifrol Extended Release Tablet 1.5mgSingapore · 1.500mg · tablet, extended release · Boehringer Ingelheim Singapore Pte. LTD.Same brand
- SIFROL TABLET 0.125 mgSingapore · 0.125mg · tablet · Boehringer Ingelheim Singapore Pte. LTD.Same brand
- MirapexinEuropean Union · Boehringer Ingelheim International GmbHSame form
- OprymeaEuropean Union · Krka, d.d., Novo mestoSame form
- MirapexinCroatiaSame form
- OprymeaCroatiaSame form
- CALMOLAN 0,26 mgRomania · 0,26mg · compr. elib. prel. · G.L. Pharma GMBHSame form
- CALMOLAN 0,52 mgRomania · 0,52mg · compr. elib. prel. · G.L. Pharma GMBHSame form
- CALMOLAN 2,1 mgRomania · 2,1mg · compr. elib. prel. · G.L. Pharma GMBHSame form
- Mixole prolonged-release tablets 0.375 mgTaiwan · 持續性藥效錠 · 美時化學製藥股份有限公司Same form
- Mixole prolonged-release tablets 0.75 mgTaiwan · 持續性藥效錠 · 美時化學製藥股份有限公司Same form
- Mixole prolonged-release tablets 1.5mgTaiwan · 持續性藥效錠 · 美時化學製藥股份有限公司Same form
- Act PramipexoleCanada · 1.5 MG · Tablet · Teva Canada LimitedSame substance
- Act PramipexoleCanada · 0.5 MG · Tablet · Teva Canada LimitedSame substance
- Act PramipexoleCanada · 1 MG · Tablet · Teva Canada LimitedSame substance
- MIRAPEXIN 0,18 mg COMPRIMIDOSSpain · 0,18 mg · comprimido · Boehringer Ingelheim International GmbhSame substance
- MIRAPEXIN 0,18 mg COMPRIMIDOSSpain · 0,18 mg · comprimido · Boehringer Ingelheim International GmbhSame substance
- MIRAPEXIN 0,26 mg COMPRIMIDOS DE LIBERACION PROLONGADASpain · 0,26 mg · comprimido de liberación prolongada · Boehringer Ingelheim International GmbhSame substance
- MirapexinItaly · Compressa a rilascio prolungato · Farmed S.R.L.Same substance
- MirapexinItaly · Compressa a rilascio prolungato · Boehringer Ingelheim International GMBHSame substance
- OprymeaItaly · Compressa a rilascio prolungato · Krka D.D. Novo MestoSame substance
- RamipexNew Zealand · Tab 0.25 mgSame substance
- RamipexNew Zealand · Tab 1 mgSame substance
- Mirapexin®Serbia · 1.05mg · tableta sa produženim oslobađanjem · Boehringer Ingelheim Serbia D.O.O. BeogradSame substance
- Mirapexin®Serbia · 2.1mg · tableta sa produženim oslobađanjem · Boehringer Ingelheim Serbia D.O.O. BeogradSame substance
- Mirapexin®Serbia · 0.52mg · tableta sa produženim oslobađanjem · Boehringer Ingelheim Serbia D.O.O. BeogradSame substance
- Pramipexole DihydrochlorideUnited States · 0.125MG, 0.25MG, 0.5MG … · tablet · AlembicSame substance
- Pramipexole DihydrochlorideUnited States · 0.375MG, 0.75MG, 1.5MG … · tablet, extended release · Actavis ElizabethSame substance
- Mirapex ERUnited States · 0.375MG, 0.75MG, 1.5MG … · tablet, extended release · Boehringer IngelheimSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Pramipexole
- Register
- Brazil (Anvisa)
- Status
- Cancelled
- Status in the register
- Inativo
- Authorised
- 3 Jun 1998
- Registration
- 103670107
- Marketing authorisation holder
- Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda.
- Procedure
- Registered